Abstract
To the Editor:— Recently interest has been aroused in hepatotoxicity in psoriasis patients with methotrexate. 1,2 One factor which may be of importance in the development of hepatotoxicity is the rate of intestinal absorption of the drug. Freeman-Narrod 3 showed that there were at least two distinct patterns of intestinal absorption of methotreaxate. The first pattern showed quite slow absorption, with low peak blood levels and slow clearing from the blood. The second pattern showed rapid absorption with high peak blood levels and rapid clearing. In addition, after several weeks of treatment, in many of the patients with the second (rapid) absorption pattern, the absorption curve altered in such a way that they became slow absorbers. The same author 3 also showed that the patient who retained a rapid methotrexate absorption pattern throughout the course of therapy did not develop signs of toxic effects. Those who were slow absorbers, or
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
